Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Background: Central obesity is associated with increased risk of cardiometabolic disease. Weight loss reduces lean muscle mass, potentially impacting resting energy expenditure and/or physical functioning. This analysis of the STEP 1 trial evaluated the impact of subcutaneous (s.c.) semaglutide, a g...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilding, John P H, Batterham, Rachel L, Calanna, Salvatore, Van Gaal, Luc F, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie T D, Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels, Kushner, Robert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089287/
http://dx.doi.org/10.1210/jendso/bvab048.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089287/
http://dx.doi.org/10.1210/jendso/bvab048.030

Ejemplares similares